Science, Policy, and Ethics

Description

Synthetic biology, “which aims to apply standardized engineering techniques to biology and thereby create organisms or biological systems with novel or specialized functions to address countless needs,”* offers the potential for tremendous benefit, alongside a range of possible risks. How should these benefits and risks be balanced, from a scientific, ethical, and policy perspective? This panel engaged a leader in the field of synthetic biology and an expert in risk regulation and policy in discussion of these issues.

Panelists

Learn More!

Couldn’t attend the event? Check out some of our presenters’ slide presentations!

This event was free and open to the public.

Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund.